See more : Stenhus Fastigheter i Norden AB (publ) (SFAST.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Tabula Rasa HealthCare, Inc. (TRHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tabula Rasa HealthCare, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Guilin Seamild Foods Co., Ltd (002956.SZ) Income Statement Analysis – Financial Results
- Bitfarms Ltd. (BITF.TO) Income Statement Analysis – Financial Results
- AAA Technologies Limited (AAATECH.NS) Income Statement Analysis – Financial Results
- Palamina Corp. (PA.V) Income Statement Analysis – Financial Results
- Panaxia Labs Israel Ltd (PNAX.TA) Income Statement Analysis – Financial Results
Tabula Rasa HealthCare, Inc. (TRHC)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.tabularasahealthcare.com
About Tabula Rasa HealthCare, Inc.
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 299.52M | 331.26M | 297.22M | 284.71M | 204.27M | 134.55M | 94.06M | 70.04M | 48.43M | 25.14M |
| Cost of Revenue | 232.60M | 233.36M | 204.81M | 181.36M | 137.67M | 93.66M | 65.18M | 49.13M | 37.81M | 20.92M |
| Gross Profit | 66.91M | 97.90M | 92.41M | 103.35M | 66.60M | 40.89M | 28.89M | 20.91M | 10.62M | 4.22M |
| Gross Profit Ratio | 22.34% | 29.56% | 31.09% | 36.30% | 32.60% | 30.39% | 30.71% | 29.86% | 21.92% | 16.79% |
| Research & Development | 14.48M | 19.79M | 18.18M | 21.74M | 12.22M | 5.63M | 3.81M | 2.88M | 1.66M | 1.34M |
| General & Administrative | 74.97M | 73.76M | 65.38M | 50.90M | 28.18M | 21.18M | 11.83M | 7.12M | 3.97M | 2.48M |
| Selling & Marketing | 10.49M | 25.97M | 21.55M | 25.27M | 9.67M | 5.54M | 3.86M | 2.88M | 2.27M | 1.78M |
| SG&A | 85.47M | 99.73M | 86.93M | 76.17M | 37.85M | 26.72M | 15.69M | 10.00M | 6.24M | 4.26M |
| Other Expenses | 23.35M | 47.71M | 45.04M | 34.28M | 16.80M | 0.00 | 639.00K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 123.30M | 167.23M | 150.15M | 132.19M | 66.87M | 41.86M | 24.62M | 16.81M | 9.72M | 6.71M |
| Cost & Expenses | 355.90M | 400.58M | 354.96M | 313.54M | 204.54M | 135.52M | 89.79M | 65.93M | 47.53M | 27.63M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.03M | 9.11M | 20.74M | 15.99M | 906.00K | 688.00K | 4.49M | 5.92M | 1.35M | 833.00K |
| Depreciation & Amortization | 31.74M | 47.71M | 45.04M | 34.28M | 16.80M | 9.51M | 5.12M | 3.93M | 1.82M | 1.12M |
| EBITDA | -24.64M | -21.62M | -20.35M | 1.63M | 16.53M | 8.54M | 3.89M | 8.04M | 2.71M | -1.76M |
| EBITDA Ratio | -8.23% | -6.53% | -4.27% | 1.91% | 8.09% | 6.35% | 9.98% | 11.48% | 5.60% | -5.46% |
| Operating Income | -56.38M | -69.32M | -57.74M | -28.83M | -49.74M | 5.20M | 4.55M | 6.17M | 107.00K | -2.49M |
| Operating Income Ratio | -18.82% | -20.93% | -19.43% | -10.13% | -24.35% | 3.87% | 4.84% | 8.80% | 0.22% | -9.91% |
| Total Other Income/Expenses | -20.56M | -9.11M | -20.74M | -15.99M | -906.00K | -688.00K | -10.26M | -6.64M | -2.41M | -1.38M |
| Income Before Tax | -76.95M | -78.43M | -86.13M | -48.64M | -50.65M | 4.51M | -5.71M | -2.54M | -1.52M | -3.87M |
| Income Before Tax Ratio | -25.69% | -23.68% | -28.98% | -17.08% | -24.79% | 3.35% | -6.07% | -3.62% | -3.13% | -15.40% |
| Income Tax Expense | 389.00K | 627.00K | -5.17M | -16.20M | -3.38M | -9.78M | 541.00K | 328.00K | -409.00K | 833.00K |
| Net Income | -77.33M | -79.06M | -80.97M | -32.44M | -47.27M | 14.30M | -6.25M | -2.86M | -1.11M | -3.87M |
| Net Income Ratio | -25.82% | -23.86% | -27.24% | -11.39% | -23.14% | 10.63% | -6.64% | -4.09% | -2.29% | -15.40% |
| EPS | -3.18 | -3.39 | -3.71 | -1.57 | -2.48 | 0.76 | -0.83 | -0.29 | -0.11 | -0.39 |
| EPS Diluted | -3.18 | -3.39 | -3.71 | -1.57 | -2.48 | 0.68 | -0.54 | -0.29 | -0.11 | -0.39 |
| Weighted Avg Shares Out | 24.29M | 23.29M | 21.82M | 20.62M | 19.10M | 16.73M | 7.49M | 9.86M | 9.86M | 9.86M |
| Weighted Avg Shares Out (Dil) | 24.29M | 23.29M | 21.82M | 20.62M | 19.10M | 18.77M | 11.59M | 9.86M | 9.86M | 9.86M |
ExactCare and Tabula Rasa HealthCare Rebrand Combined Organization as AnewHealth
ExactCare and Tabula Rasa HealthCare Business Combination Closes, Creating a Leading, Independent Value-Based Pharmacy Management Company for Patients with the Most Complex Needs
Tabula Rasa HealthCare Stockholders Approve Acquisition by Nautic Partners
TABULA RASA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tabula Rasa HealthCare, Inc. - TRHC
TABULA RASA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tabula Rasa HealthCare, Inc. - TRHC
TABULA RASA SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of $10.50 Per Share Buyout Agreement - TRHC
Why Shares of Tabula Rasa HealthCare Are Soaring Monday
Compared to Estimates, Tabula Rasa Healthcare (TRHC) Q2 Earnings: A Look at Key Metrics
Tabula Rasa Healthcare (TRHC) Q2 Earnings and Revenues Surpass Estimates
TRHC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Tabula Rasa Healthcare, Inc. Is Fair to Shareholders
Source: https://incomestatements.info
Category: Stock Reports